Podcasts about Curative

  • 174PODCASTS
  • 215EPISODES
  • 32mAVG DURATION
  • 1WEEKLY EPISODE
  • Mar 19, 2025LATEST

POPULARITY

20172018201920202021202220232024


Best podcasts about Curative

Latest podcast episodes about Curative

Ordinary Mind Zen School
Curative Fantasies

Ordinary Mind Zen School

Play Episode Listen Later Mar 19, 2025 8:04


Curative Fantasies by Ordinary Mind Zen School

Healthed Australia
Revolutionising curative treatment for prostate cancer

Healthed Australia

Play Episode Listen Later Mar 10, 2025 42:24


Radiation therapy plays a big role as a curative treatment option for prostate cancer External Beam Radiation Therapy (EBRT) and Brachytherapy are the two primary types of radiation therapy used to treat prostate cancer Surgical isn’t the only option, radiation therapy can also cure some prostate cancers Advantages of radiation therapy – outpatient procedure, doesn’t involve anaesthetics, less potential side effects etc Healthcare professionals play a crucial role in the early stages of prostate cancer diagnosis. They are encouraged to discuss radiation therapy as a treatment option and refer patients to a radiation oncologist for further evaluation and treatment planning Host: Dr David Lim | Total Time: 42 mins Experts: Prof Sandra Turner, Staff Specialist Radiation Oncologist and A/Prof Lucinda Morris, Radiation Oncologist Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEDT Click here to register for the next oneSee omnystudio.com/listener for privacy information.

BackTable Podcast
Ep. 521 Surgery for HCC: What's its Role Today?

BackTable Podcast

Play Episode Listen Later Feb 28, 2025 46:11


Is surgery truly the "cure" for hepatocellular carcinoma (HCC), and when is it a viable option? In this episode, Dr. Sabeen Dhand leads a roundtable discussion with interventional radiologist Dr. Siddharth Padia and transplant/hepatobiliary surgeons Dr. John Seal and Dr. Gabriel Schnickel, delving into the complexities of surgical treatments for HCC and the evolving landscape of liver resection and transplantation. Physicians, nurses, nurse practitioners, and physician assistants can follow this link to earn CME / CE credits for completing an accredited learning activity related to this discussion: https://www.cmeuniversity.com/course/take/125741 --- This podcast is supported by an educational grant from AstraZeneca Pharmaceuticals and Boston Scientific. --- SYNPOSIS The doctors begin by discussing how they manage patient expectations regarding both palliative and curative treatments, highlighting the risk of recurrent HCC as a new lesion. They then outline key factors that influence their recommendations for liver transplant versus resection, such as the extent of underlying liver disease, the function of the future liver remnant, body habitus, overall health, and organ availability. The surgeons also review various surgical approaches to liver resection and recent advancements in liver transplantation, including living donor transplants and the ability to refer patients for downstaging procedures. Dr. Padia explains the original role of Y90 as a bridging treatment to downstage tumors and promote hypertrophy in the non-diseased liver segments, preparing the organ for surgical resection. However, Y90 treatment can also lead to the formation of adhesions, which may complicate future surgeries. Finally, the doctors discuss strategies to improve care coordination between community physicians and transplant centers to optimize patient outcomes. --- TIMESTAMPS 00:00 - Curative vs. Palliative Treatment 04:03 - Choosing Between Transplantation and Resection 05:47 - Liver Resection Types 07:27 - Bridging Role of Y90 12:14 - Evolving Landscape of Liver Transplantation 20:59 - Patient Counseling in Minimally Invasive Procedures 28:40 - Considerations for Surgery After Y90 33:32 - Coordination Between Specialists 40:08 - Immunotherapy as a Bridge to Transplant --- RESOURCES CME Accreditation Information: https://f7cae4ec-b69e-490d-9e0f-19b16a6f146d.usrfiles.com/ugd/f7cae4_a7c37ea3cd1b4d3fa53d5edf8dfe255b.pdf

Dog Cancer Answers
Is Radiation Therapy Dangerous for Dogs? The Truth from A Vet Tech | Jenny Fisher #273

Dog Cancer Answers

Play Episode Listen Later Feb 10, 2025 55:34


In this in-depth expose, veterinary oncology technician specialist Jenny Fisher joins Molly Jacobson to explain the ins and outs of radiation therapy for dogs with cancer. Whether you're fearful as you consider radiation for your dog or just curious about how it works, this episode provides invaluable insights.  Topics Covered:  How radiation therapy works and the two types: diagnostic vs. therapeutic  The difference between teletherapy and brachytherapy  What to expect during radiation treatments, including anesthesia use  Short-term and long-term side effects of radiation therapy  When radiation therapy is recommended for dogs with cancer  How stereotactic radiosurgery like CyberKnife offers precision treatment  Tips for preparing your dog for radiation therapy and managing side effects  Your Voice Matters!   If you have a question for our team, or if you want to share your own hopeful dog cancer story, we want to hear from you! Go to https://www.dogcancer.com/ask to submit your question or story, or call our Listener Line at +1 808-868-3200 to leave a question.   Related Videos:  Radiation for a dog with TCC: https://www.youtube.com/watch?v=ZGoyn-1TBsA  What a veterinary technician does: https://www.youtube.com/watch?v=9m7pjiHLhGA   Related Links:  An overview of radiation therapy for dogs: https://www.dogcancer.com/articles/diagnosis-and-medical-procedures/radiation-for-dogs/  An in-depth article on stereotactic radiation: https://www.dogcancer.com/articles/diagnosis-and-medical-procedures/stereotactic-radiation-therapy-for-dogs/   Chapters:  00:00 Introduction  0:15 What Is Radiation Therapy for Dogs?  01:00 Types of Radiation: Teletherapy vs. Brachytherapy  02:45 Common Misconceptions About Radiation Safety  04:00 How Teletherapy Works for Dogs  06:30 The Role of Anesthesia in Radiation Therapy  08:45 How Radiation Targets Tumors  10:30 Curative vs. Palliative Radiation Intent  12:15 Stereotactic Radiosurgery Explained  14:00 Managing Side Effects: Short-Term and Long-Term Effects  18:00 Radiation-Induced Tumors: Risks and Realities  20:30 Preparing Your Dog for Radiation Therapy  23:00 How Technicians Create a Healing Environment  25:15 Tips for Dog Owners: What to Ask Your Vet  27:00 Closing Thoughts: Changing Perceptions Around Radiation    Get to know Jenny Fisher: https://www.dogcancer.com/people/jenny-cassibry-fisher-rvt-vts-oncology/  For more details, articles, podcast episodes, and quality education, go to the episode page: https://www.dogcancer.com/podcast/   Learn more about your ad choices. Visit megaphone.fm/adchoices

BackTable Podcast
Ep. 515 Curative Intent Therapies for HCC: Today and Tomorrow

BackTable Podcast

Play Episode Listen Later Feb 7, 2025 52:23


For hepatocellular carcinoma (HCC) patients who are not candidates for liver transplant or resection, lesion ablation can be a curative treatment. With multiple ablation options available and still under investigation, it can be challenging to navigate the differences between them. In this episode, Dr. Tyler Sandow hosts a discussion with interventional radiologists Dr. Kirema Garcia-Reyes, Dr. Sabeen Dhand, and Dr. Kevin Burns on the various ablation options for HCC and when to use each one. Physicians, nurses, nurse practitioners, and physician assistants can follow this link to earn CME / CE credits for completing an accredited learning activity related to this discussion: https://www.cmeuniversity.com/course/take/125738" --- This podcast is supported by an educational grant from: AstraZeneca https://www.astrazeneca.com/our-therapy-areas/oncology.html With additional support from: Boston Scientific https://www.bostonscientific.com/en-US/medical-specialties/interventional-radiology/interventional-oncology.html --- SYNPOSIS The doctors first discuss Barcelona-Clinic Liver Cancer (BCLC) Stage A patients, where lesion size and location are key factors in deciding between ablation and transarterial therapies. They then compare cryoablation and microwave ablation, highlighting that cryoablation offers better visualization and control of the ablation zone, while microwave ablation is more effective for treating larger lesions. Dr. Burns introduces histotripsy, a noninvasive treatment that uses ultrasound energy to mechanically ablate tumors. He shares his experiences as an early adopter of this technology and discusses how intraoperative cone beam CT can help treat lesions located near critical structures or those poorly visualized on ultrasound. Finally, Dr. Garcia-Reyes and Dr. Berman provide insights into patient selection, pre-procedural imaging, and technical tips for Y90. --- TIMESTAMPS 00:00 - Introduction 02:04 - Ablation vs Y90 in BCLC A Patients 05:58 - Same-Day Y90 15:55 - Y90 for Large Tumors 17:51 - Ideal Cases for Cryoablation 19:38 - Explanation of Histotripsy 32:09 - Procedural Specifics for Histotripsy 38:21 - Technical Tips for Y90 --- RESOURCES Including the Hollow Viscera (Stomach or Bowel) within the Ice Ball during Cryoablation: A Review of Adverse Events (Abramyan et al, 2024): https://www.jvir.org/article/S1051-0443(24)00681-X/abstract

PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast
David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast

Play Episode Listen Later Feb 4, 2025 47:14


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPF865. CME credit will be available until January 26, 2026.Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Play Episode Listen Later Feb 4, 2025 47:14


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPF865. CME credit will be available until January 26, 2026.Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast
David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

Play Episode Listen Later Feb 4, 2025 47:14


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPF865. CME credit will be available until January 26, 2026.Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

PeerView Internal Medicine CME/CNE/CPE Video Podcast
David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

PeerView Internal Medicine CME/CNE/CPE Video Podcast

Play Episode Listen Later Feb 4, 2025 47:14


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPF865. CME credit will be available until January 26, 2026.Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

PeerView Internal Medicine CME/CNE/CPE Audio Podcast
David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

PeerView Internal Medicine CME/CNE/CPE Audio Podcast

Play Episode Listen Later Feb 4, 2025 47:14


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPF865. CME credit will be available until January 26, 2026.Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

Play Episode Listen Later Feb 4, 2025 47:14


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPF865. CME credit will be available until January 26, 2026.Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast
David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

PeerView Heart, Lung & Blood CME/CNE/CPE Audio Podcast

Play Episode Listen Later Feb 4, 2025 47:14


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPF865. CME credit will be available until January 26, 2026.Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

PeerView Clinical Pharmacology CME/CNE/CPE Video
David R. Spigel, MD, FASCO - Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches

PeerView Clinical Pharmacology CME/CNE/CPE Video

Play Episode Listen Later Feb 4, 2025 47:14


This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZPF865. CME credit will be available until January 26, 2026.Charting a New Course in Limited-Stage SCLC Amid an Immunotherapy Sea Change: Elevating Curative-Intent Treatment Approaches In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from AstraZeneca.Disclosure information is available at the beginning of the video presentation.

Talking Talmud
Sanhedrin 47: The Curative Graves of the Sages

Talking Talmud

Play Episode Listen Later Feb 1, 2025 17:47


If a person ate of the forbidden fats, he needs to bring a sin-offering to atone for it. But if he decides to stop observing the mitzvot between the time of the sin and the sin-offering - and then decides to come back to his observance, he pushed aside the animal and the sin-offering. Can the same animal be used, or once it's been pushed side, is that it? What if the person loses cognitive abilities as an interim instead? (And why does the Gemara need to present both cases?) Also, people would take dirt from Rav's grave as a cure for a fever of one day. Which is difficult, but Shmuel allows it. And a verse suggests that this practice was acceptable, given that it doesn't go as far as acts that were known to be idolatrous. Plus, that which was attached to the ground is not a problem of idolatry. One question is how this relates to other graveyard prayers and traditions.

R Yitzchak Shifman Torah Classes
Shabbos 109b Recap- Curative Foods on Shabbos, Cures for Various Ailments (A/Y)

R Yitzchak Shifman Torah Classes

Play Episode Listen Later Dec 12, 2024 4:26


2 sections- consumption of foods that are medical vs regular food on Shabbos, series of cures for various ailments/sicknesses

R Yitzchak Shifman Torah Classes
Shabbat 109b- Curative Foods on Shabbat, Cures for Various Ailments (A/Y)

R Yitzchak Shifman Torah Classes

Play Episode Listen Later Dec 12, 2024 56:01


2 section- consumption of foods that are medical vs regular foods on Shabbat, series of cures for various ailments/sicknesses

BenefitsPRO-Perspectives's podcast
How Curative humanizes benefits by eliminating financial barriers to care

BenefitsPRO-Perspectives's podcast

Play Episode Listen Later Oct 15, 2024 16:00


Founded as a COVID-19 testing firm, Texas-based Curative has pivoted into employee benefits with a unique approach: No copays and no deductibles as long as members complete a Baseline Visit or orientation to the plan within the first 120 days. As a member of the Luminaires Class of 2024, Curative is being recognized in the category of Humanizing Benefits. CEO and co-founder Fred Turner recently sat down with BenefitsPRO contributor Michael Krieger to discuss how the company's approach helps expand coverage by removing financial barriers to quality health care.

Real Estate Power Play
EP 135 Is there Money in Curative Title? | With Logan Fullmer & Host Gabe Rodarte

Real Estate Power Play

Play Episode Listen Later Oct 8, 2024 38:55


In our latest episode of the Real Estate Power Play Podcast, we're diving deep into Curative Title with expert Logan Fullmer. If you've been wondering whether there's real profit in resolving title issues, this episode is packed with insights you don't want to miss!

Hypnosis and relaxation |Sound therapy
The relief of anxiety and inner comfort. The words of the Dragon King and the words of the Phoenix achieve miraculous curative effects

Hypnosis and relaxation |Sound therapy

Play Episode Listen Later Sep 29, 2024 29:53


Support this podcast at — https://redcircle.com/hypnosis-and-relaxation-sound-therapy9715/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Maino and the Mayor
Curative Connection (Hour 2)

Maino and the Mayor

Play Episode Listen Later Sep 23, 2024 44:18


Sean Franken & Brenda Jordan join the guys to talk about an event coming up to raise money for Curative Connections. If you're not aware of the work that Curative does, for more than 70 years they've been here to help families, seniors and people with disabilities find support and care due to aging, dementia, brain injury or other disability. You can find more details about their Kick It Off for Curative by clicking HERE. Maino and the Mayor is a part of the Civic Media radio network and airs Monday through Friday from 6-9 am on WGBW in Green Bay and on WISS in Appleton/Oshkosh. Subscribe to the podcast to be sure not to miss out on a single episode! To learn more about the show and all of the programming across the Civic Media network, head over to https://civicmedia.us/shows to see the entire broadcast line up. Follow the show on Facebook and X to keep up with Maino and the Mayor! Guests: Sean Franken, Brenda Jordan

The Healers Café
The Link Between Mental & Physical Health & Ketamine's Role in Treatment with Jorge Padron on The Healers Cafe

The Healers Café

Play Episode Listen Later Sep 18, 2024 30:55


In this episode of The Healers Café, Manon Bolliger, FCAH, RBHT (facilitator and retired naturopath with 30+ years of practice) speaks with Jorge Padron about the impact of psychedelics like ketamine on mental health and the connection between physical and mental well-being. For the transcript and full story go to: https://www.drmanonbolliger.com/jorge-padron          Highlights from today's episode include: Jorge Padron trust, right? Because so many times people build up the walls because they don't want anything getting in, but then you can't get out either. So now you're trapped in with all your, you know, 20 feet walls you built up so the world can't get in, but you can't get. Jorge Padron it's like, you know. You're going to be with yourself for, let's just say, 80 years of your life, and you're never going to check in with yourself? You're just going to believe what everybody else is telling you, what is what they're telling you is not necessarily good for you, and you only really know that if you know Manon Bolliger you know, when you say the conversation with self, I mean, we're in society where we're trying to have a conversation with a doctor. That's already something, but to have a conversation with oneself, you become your your best, your second best opinion, right? And it could be the best opinion.   ABOUT JORGE PADRON: I have 12 years of healthcare experience in various areas such as ICU, trauma, and psychiatry. I trained in psychedelic assisted therapy at California Institute of Integral Studies and ketamine therapy with Dr. Phil Wolfson. Currently, I am engaged with the AWE psychedelic training program. Core purpose/passion: I am passionate about helping people see a way out of their mental health struggles instead of pathologizing every difficult experience. This requires more time and effort as sometimes to get better, we have to get comfortable with not knowing or uncertainty to produce a change in somebody's life. Website | LinkedIn |   ABOUT MANON BOLLIGER, FCAH, RBHT  As a de-registered (2021) board-certified naturopathic physician & in practice since 1992, I've seen an average of 150 patients per week and have helped people ranging from rural farmers in Nova Scotia to stressed out CEOs in Toronto to tri-athletes here in Vancouver.  My resolve to educate, empower and engage people to take charge of their own health is evident in my best-selling books:  'What Patients Don't Say if Doctors Don't Ask: The Mindful Patient-Doctor Relationship' and 'A Healer in Every Household: Simple Solutions for Stress'.  I also teach BowenFirst™ Therapy through and hold transformational workshops to achieve these goals. So, when I share with you that LISTENING to Your body is a game changer in the healing process, I am speaking from expertise and direct experience". Manon's Mission: A Healer in Every Household!  For more great information to go to her weekly blog:  http://bowencollege.com/blog.    For tips on health & healing go to: https://www.drmanonbolliger.com/tips   Follow Manon on Social – Facebook | Instagram | LinkedIn | YouTube | Twitter | Linktr.ee | Rumble   ABOUT THE HEALERS CAFÉ:  Manon's show is the #1 show for medical practitioners and holistic healers to have heart to heart conversations about their day to day lives.  Subscribe and review on your favourite platform: iTunes | Google Play | Spotify | Libsyn | iHeartRadio | Gaana | The Healers Cafe | Radio.com | Medioq |   Follow The Healers Café on FB: https://www.facebook.com/thehealerscafe     Remember to subscribe if you like our videos. Click the bell if you want to be one of the first people notified of a new release. * De-Registered, revoked & retired naturopathic physician after 30 years of practice in healthcare. Now resourceful & resolved to share with you all the tools to take care of your health & vitality!  

Becker’s Payer Issues Podcast
Fred Turner, CEO of Curative

Becker’s Payer Issues Podcast

Play Episode Listen Later Sep 6, 2024 12:42


In this episode, Fred Turner, CEO of Curative, shares the journey of scaling the company from a COVID-19 testing powerhouse to a disruptive force in the commercial health plan space. He discusses Curative's unique no-deductible model, the importance of early patient engagement, and the challenges of entering a highly regulated industry dominated by a few major players.

Maino and the Mayor
Curative Connections & Veteran Salute (Hour 2)

Maino and the Mayor

Play Episode Listen Later Jul 30, 2024


The hour begins with Sean Franken who is the Director of the Employment and Training program at Curative Connections. Curative helps people achieve their goals for independence. Sean works with folks and helps to get them prepared to work and look toward their future. You can find more details on Curative Connections by clicking HERE. Then Brian Eisch, a veteran who served and protected our Country for 20 years in the United States Army joins the show. He was shot three times in Afghanistan while trying to rescue an Afghan National Police Officer who was severely wounded in an ambush. Get more information on Brian's life HERE. Maino and the Mayor is a part of the Civic Media radio network and airs Monday through Friday from 6-9 am on WGBW in Green Bay and on WISS in Appleton/Oshkosh. Subscribe to the podcast to be sure not to miss out on a single episode! To learn more about the show and all of the programming across the Civic Media network, head over to https://civicmedia.us/shows to see the entire broadcast line up. Follow the show on Facebook and X to keep up with Maino and the Mayor! Guests: Sean Franken, Brian Eisch

Talking Precision Medicine
Cell therapy for T-cell malignancies—the science and business of developing curative medicines for patients in need | Talking Precision Medicine #37

Talking Precision Medicine

Play Episode Listen Later Jul 22, 2024 39:01


In this episode I chat with Dr Sarah Hein, co-founder and CEO of March Biosciences, a Houston Based biotech developing cell therapies for T-cell malignancies. Sarah is an old friend and colleague from our days as trainees at Baylor College of Medicine, where we both circulated among those with ambitions of entrepreneurship. Sarah has definitely made good in that regard, as a serial entrepreneur deeply enmeshed in Houston's growing life sciences and healthtech ecosystem. Episode 37 links: ⁠⁠⁠⁠TPM E37⁠⁠⁠ for highlights and links from this episode >⁠ ⁠Genialis' Upcoming Events⁠ ⁠Genialis™ krasID

Bright Spots in Healthcare Podcast
Everything You Thought about Value-Based Care Is Wrong: A Plan CEO Tells You Why

Bright Spots in Healthcare Podcast

Play Episode Listen Later Jun 12, 2024 34:52


Fred Turner, co-founder and chief executive officer of Curative, joins Eric to discuss how Curative is reinventing health insurance by adopting a more preventative approach to drive better results and lead to a more affordable delivery of plans.   Fred shares Curative's journey from a pandemic testing company to a health insurance provider with a first-of-its-kind plan that eliminates copays and deductibles and advocates that the most effective approach to promote early preventive care is ensuring accessible and cost-free access to top-tier healthcare providers.   Fred underlines the significance of simplifying the healthcare system and the positive impact of Curative's approach. The innovative health insurance plan offers unmatched transparency into healthcare costs, providing reassurance to both employees and employers about the affordability and accessibility of healthcare.    Tune in and learn what makes Curative different from other plans and how it makes health care affordable, accessible and engaging for members. About Fred Fred Turner is the Chief Executive Officer and co-founder of Curative. A British scientist from West Yorkshire, Turner attended the University of Oxford. Fred was named one of the top 100 practicing scientists in the UK by the Science Council in 2013. Turner was included in Forbes “30 Under 30” list and ranked first in the European Union Contest for Young Scientists.    About Curative Curative has been critical and a national leader in bringing COVID-19 testing and vaccine-administration resources in response to the pandemic, providing more than 32 million tests and two million vaccines across thousands of locations in 40+ states. Concurrently, Curative has created and launched a first-of-its-kind health insurance plan offering that offers unmatched transparency into health care costs.

Ideas That Make An Impact: Expert and Author Interviews to transform your life and business
#353 Harnessing the Power of Cash Flow: A Curative Approach to Business | David Wiener

Ideas That Make An Impact: Expert and Author Interviews to transform your life and business

Play Episode Listen Later May 22, 2024 17:04


3 big ideas discussed in this episode:  BIG IDEA #1: Many businesses do not have a handle on cash flow. BIG IDEA #2: Don't try to do it all yourself. BIG IDEA #3: Don't overpay your taxes. Enjoy the interview  Get the show notes for this episode here: https://AskJeremyJones.com/353

PVRoundup Podcast
Specialist Spotlight: Neoadjuvant Approach to Urothelial Carcinoma: Treatment With Curative Intent

PVRoundup Podcast

Play Episode Listen Later May 13, 2024 13:09


Drs. Rosenberg and Morgans share their insights into neoadjuvant therapy in the management of patients with muscle invasive urothelial carcinoma, including patient‑ and treatment‑related factors that may influence decision making, bladder‑preservation, and the future of neoadjuvant therapy with immunotherapy and ADCs.

Cider Chat
411: Curative Options for Cider Making Problems | CiderCon 2024

Cider Chat

Play Episode Listen Later May 1, 2024 61:51


Technical Tips for When Things Go Wrong with Cider Making This episode features two cider professionals and a cider industry consultant, which is exactly who you need a direct line to when your cider has problems. Hear from Megan Faschoway who at the time of this recording was Senior Cider Maker at Sea Cider, Kira Bassingthwaighte Head Cider Maker at Western Cider in Montana and Nick Gunn of BenchGraft a cider consultation service based in Salem Oregon. This talk took place in Portland Oregon at CiderCon, the annual cider conference hosted by the American Cider Association. The title of the talk was “What to do when things go wrong”. The focus was not on preventive measures, but as the title says – curative steps that one can take to try to mitigate a problem with a particular cider In this Cider Chat on Cider Problems Dealing with rotten egg smell from your cider Hydrogen sulfide (H2S) is a negative off-aroma compound that can occur in cider and has a rotten egg smell. It's produced by the yeast Saccharomyces cerevisiae during cider fermentation. Filtering cider Using Reverse Osmosis (RO) Tasting Panels for feedback Dealing with a saturated cider maker's palate Saving samples from each batch to create a library for potential cider problems down the road Contact for Speakers on this Panel Kira Bassingthwaighte, Western Cider Hear Kira on Episode 295 Megan Faschoway Nick Gunn BenchGraft Hear Nick and Dave White of Whitewood Cider on Episode 004 Mentions in this Cider Chat French Cider Tour September 2024 Oliver's Cider and Perry Company – UK Cider in Herefordshire, Tom Oliver audio clip The Whose Who of #xpromotecider in this episode? Join the fun and download the info flyer on Cider Chat offerings at the Support Page! Post, share and social media and tag Cider Chat! Cider's XPromoters will be featured on an end of year episode!   De Gerdenner Cider, Netherland Northwest Cider Association reposted Episode 410 with Olympic Bluffs Cider and Lavender Farm Ross on Wye Cider and Perry Company posted last week's Episode 410 Perry Panel Dragon' Head Cider Camra Cider and Perry American Cider Association – CiderCon

BioTalk Unzipped
Breakthrough in Melanoma, Rare Diseases, and Curative Therapies with Scott Schliebner

BioTalk Unzipped

Play Episode Listen Later Apr 15, 2024 36:43


Summary In this episode, Scott Schliebner discusses the unique challenges and complexities of rare disease trials. He highlights the difficulties in recruiting patients, the multidisciplinary nature of care, and the importance of collaboration among various stakeholders. The role of AI in rare disease trials is also explored, with a focus on its potential for patient recruitment and data analysis.  Scott shares success stories in the field and discusses the expanding use of gene therapy to target multiple genes. The conversation concludes with a discussion on the recent FDA approval of Iovance's Amtogvy as the first T-cell therapy for a solid tumor, Melanoma. In this conversation, Scott discusses the potential of cell therapy in targeting solid tumors, particularly melanoma. He highlights the importance of expanding the use of cell therapy to other tumor types and the potential for curative treatments. The conversation also delves into the challenges and questions surrounding pricing and ethics in the gene and cell therapy space. The impact of curative therapies on quality of life and healthcare costs is explored, along with the success of curative therapies in hepatitis C. The high bar of clinical development and regulatory standards is discussed, as well as the potential for cost-effective treatments. The conversation concludes with advice for young professionals and established clinical professionals in the field of drug development. Takeaways Cell therapy shows promise in targeting solid tumors, such as the breakthrough in melanoma treatment, and has the potential to provide curative treatments for various cancer types. The pricing and ethical considerations surrounding gene and cell therapy raise important questions about accessibility and affordability. Curative therapies have the potential to significantly improve quality of life and reduce healthcare costs by eliminating the need for long-term treatments. The success of curative therapies in hepatitis C demonstrates the potential for similar breakthroughs in other disease areas. Young professionals interested in a career in clinical drug development should seek opportunities to gain experience and consider starting in roles such as clinical research coordinators or clinical research associates. Rare Givers is a nonprofit organization that supports caregivers in the rare disease space. Chapters 00:21 - Collaborative Approach in Rare Disease Trials 3:32 - The Role of AI in Rare Disease Trials 6:11 - Success Stories in Rare Disease Trials 11:34 - Expanding Gene Therapy to Target Multiple Genes 16:56 - New News: FDA Approval of Iovance's Amtagvi, The Breakthrough of IOVANCE for Melanoma 19:27 - Targeting Solid Tumors with Cell Therapy, Expanding the Potential of Cell Therapy 20:23 - The Impact of Curative Therapies on Quality of Life and Healthcare Costs 21:11 - Challenges and Questions around Pricing and Ethics 22:37 - Cures for Hepatitis C 23:25 - The High Bar of Clinical Development and Regulatory Standards 24:05 - Pricing Considerations for Different Cancer Types, The Potential for Cost-Effective Treatments 27:45 - Advice for Young Professionals in Clinical Drug Development 31:49 - Advice for Established Clinical Professionals 33:21 - Scott's Hobbies and Interests Learn about and DONATE to Rare Givers: https://www.raregivers.global/  How to reach us: Scott Schliebner https://www.linkedin.com/in/scott-schliebner-1087789/  Dr. Chad Briscoe https://www.linkedin.com/in/chadbriscoe/  Gregory Austin https://www.linkedin.com/in/gregoryaustin1/ New News Link: https://www.fiercepharma.com/pharma/fda-approves-iovances-amtagvi-first-cell-therapy-solid-tumor  Image Credits Iovance, https://www.iovance.com/  FDA approved, https://www.tipranks.com/news/iovance-nasdaqiova-fda-approves-cell-therapy-stock-gains Amtagvi, https://www.amtagvi.com/ 

Outcomes Rocket
Your Health Insurer Doesn't Want You To Listen To This: Interview with Curative CEO & co-founder Fred Turner

Outcomes Rocket

Play Episode Listen Later Apr 5, 2024 10:13


While many insurance plans include preventive care, Curative's distinctive feature is providing 100% coverage for all in-network care to actively promote prevention. In this episode, Fred Turner, co-Founder and CEO of Curative, shares insights into the dire need for transformation in employer-sponsored health insurance, addressing the issues faced by both employees and employers. He discusses the company's unique model that focuses on providing preventative care with zero out-of-pocket costs for members during the first 120 days. Fred also emphasizes the importance of simplifying the healthcare system and highlights the positive impact Curative's approach has on both employees and employers. Fred sheds light on the skepticism and reluctance of employers to adopt new health plans but emphasizes the significant impact experienced by those who embraced Curative's approach.  Tune in to learn more about the inspiring work Fred and his team are doing to revolutionize healthcare and improve access to quality care. Resources: Connect with and follow Fred Turner on LinkedIn. Follow Curative on LinkedIn and visit their website.

Behind the Case: An ACG Case Reports Journal Podcast
Curative Resection of T1a Inlet Patch Adenocarcinoma With Traction-Assisted Endoscopic Submucosal Dissection

Behind the Case: An ACG Case Reports Journal Podcast

Play Episode Listen Later Mar 27, 2024 19:00


Title Talks
Ep. 58: Avoiding Curative and Quiet Title with This Post-Closing Step

Title Talks

Play Episode Listen Later Feb 21, 2024 42:09


It's easy to forget or skip after you issue the policy, but the implications of one missed release or satisfaction can mean costly curative, delayed closings, and unhappy customers down the line. According to our guest and curative expert, Ayla Pettyjohn "An ounce of release tracking is worth a pound of curative work." Today we're joined by Pettyjohn and David Harrington from PropLogix. They're here to tell us all about what Lien Release Tracking is and how it can stop many title issues before they ever happen. To get to those resources we mentioned, visit our website: https://www.proplogix.com/podcasts/ep-58/

Small Town Summits
(Article) The Curative Power of the Gospel and Fighting “Terminal” Cancer by Ian Shearer

Small Town Summits

Play Episode Listen Later Feb 5, 2024 9:07


This episode is a recording of Ian Shearer's STS article "⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Curative Power of the Gospel and Fighting “Terminal” Cancer⁠.⁠" We pray this article from the archives is a blessing and an encouragement to you. You can find more STS Articles at ⁠⁠⁠⁠⁠⁠⁠⁠https://www.smalltownsummits.com/articles⁠⁠⁠⁠⁠⁠⁠⁠. For more information on Small Town Summits, please visit our website here: ⁠⁠⁠⁠⁠⁠⁠⁠www.smalltownsummits.com⁠⁠⁠⁠⁠⁠⁠⁠ To partner with us financially, give here: ⁠⁠⁠⁠⁠⁠⁠⁠https://www.smalltownsummits.com/give⁠⁠⁠⁠⁠⁠⁠⁠ To see more details regarding next steps and financial needs, ⁠⁠⁠⁠⁠⁠⁠⁠view this PDF⁠⁠⁠⁠⁠⁠⁠⁠. To volunteer your time and talents, email us here: ⁠⁠⁠⁠⁠⁠⁠⁠SmallTownSummits@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠ To stay up to date on how to pray, subscribe to our newsletter here: ⁠⁠⁠⁠⁠⁠⁠⁠https://www.smalltownsummits.com/contact

Talking Talmud
Bava Kamma 80: The Curative Properties of Goat Milk

Talking Talmud

Play Episode Listen Later Jan 21, 2024 20:54


More on the prohibition against raising certain small animals. Plus, the story of a pious person who had pain in his heart, and the doctors had no cure except for fresh goat milk from the source. Also, the respect paid to rabbis by each other, and the prohibition against owning a cat (especially white cats; black cats might be okay). Plus, signing on the dotted line to purchase a home in the land of Israel, even on Shabbat.

Oncology Data Advisor
Improving End-of-Life Care for Patients With AML Receiving Non-Curative Therapy: Richa Thakur, MD

Oncology Data Advisor

Play Episode Listen Later Jan 8, 2024 9:34


At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. Part 2 of this podcast series features exclusive conversations on nurse navigation to reduce socioeconomic disparities in leukemia treatment, dose reduction strategies to improve quality of life, the importance of diet in multiple myeloma, coping strategies during transplantation, and much more!

The Tom Barnard Show
Tom Barnard Show: Hour 2 - Giving 110% is so 20th century, as is curative decapitation

The Tom Barnard Show

Play Episode Listen Later Jan 3, 2024 63:57


In the first hour SKOR North's Judd Zulgad talks how the Twins, despite Tom's vow to not get worked up over things, will no doubt make him mad every summer and about the current coaching status of Minnesota Sports, KSTP's Chris Egert shares info on an overnight fire in the Twin Cities that led to one adult and six children being hospitalized, how the warm weather is impacting winter events in Minnesota, along with other top news stories of the day. Hour #2 has the secret to how you can get away with giving only 85% effort at work, and the crew learns about how John Mellencamp got his head cut off at an early age, despite how outlandish it sounds. In hour #3 Kristyn Burtt discusses "cautious comedy". Specifically, the fact that it sucks. It's probably more abundant than it's ever been, but it's definitely not new. We just remember the good stuff because, well, who's going to remember the bland? On the Family, it's time to stop using seed oils. Also, keep an eye on that smoke point. We're obsessed with slaying it in the kitchen, and not letting your oil start on fire is an epic kitchen hack. Wait, do people still say "epic"? Stream the show LIVE on the Tom Barnard Show app M-F from 8-12PM or get the show on-demand on Apple Podcasts, Spotify or wherever you get your podcasts! Learn more about your ad choices. Visit megaphone.fm/adchoices

HLTH Matters
S4 Ep18: Your Health Insurer Doesn't Want You To Listen To This — Featuring Curative CEO & co-founder Fred Turner

HLTH Matters

Play Episode Listen Later Dec 20, 2023 10:13


About Fred Turner:Fred Turner is the Chief Executive Officer and co-founder of Curative. Turner was named one of the top 100 practicing scientists in the UK by the Science Council in 2013. He was also included in Forbes' ‘30 Under 30' list and ranked first in the European Union Contest for Young Scientists. Recently, Fred was awarded Comparably's Best CEO Award and Modern Healthcare's Top 25 Emerging Leaders in 2021.Under Turner's leadership, Curative launched a first-of-its-kind health insurance plan that offers unmatched transparency into healthcare costs. Inspired by his vision to create a healthcare system that works for and supports patients' whole health through every step of their personal health journey, Turner and the Curative team developed a path-breaking health plan with no copays, no deductibles, and no cost-sharing for its members.Previously, Turner led Curative as it became the national leader in bringing COVID-19 testing and vaccine administration resources to people in response to the pandemic, providing more than 36 million tests and two million vaccines across thousands of locations in more than 40 states. Before creating both of Curative's highly innovative business models, Fred founded and led a 16z and YC-backed diagnostics (Dx) startup that built a CLIA lab for validating and launching an STD testing product in Menlo Park, California.Things You'll Learn:High Deductible Health Plans (HDHP) are leaving insured individuals functionally uninsured, unable to afford out-of-pocket costs for care.Curative's unique model offers 120 days of no out-of-pocket cost for in-network care, promoting preventative care and simplifying health benefits.Employers experiencing rising insurance costs can benefit from exploring new options like those offered by Curative to better support their employees' health and well-being.The importance of making healthcare access and benefits clear and straightforward. Curative's approach yields an impressive 98% member engagement rate, demonstrating the effectiveness of its model in promoting proactive health management.Resources:Connect with and follow Fred Turner on LinkedIn.Follow Curative on LinkedIn and visit their website.

Tuning Into The C-Suite
127: Tackling Medical Debt Challenges for Middle-Class Americans and Inclusive Healthcare Solutions, per Curative CEO Fred Turner

Tuning Into The C-Suite

Play Episode Listen Later Dec 6, 2023 18:24


Briana Contreras, an editor of Managed Healthcare Executive, spoke with Fred Turner, CEO of Curative, in this month's episode. The two talked about the challenges middle-class Americans face in dealing with medical debt, exploring the causes behind it and the impact on overall health. Fred also touched on potential solutions, both from the perspective of organizations like Curative and through collaborative efforts between various stakeholders in the healthcare system. The solutions mentioned in the conversation focus on making healthcare more financially accessible and creating a sustainable and inclusive healthcare system for all Americans.

Revision Path
Sam Viotty

Revision Path

Play Episode Listen Later Dec 4, 2023 72:08


We're exploring the intersections of design, music, and social impact with this week's guest, Sam Viotty. Not only is Sam an extremely knowledgeable program and experience designer, but she's also the co-owner of a record label and she's an adjunct professor at Loyola's Quinlan School of Business. And that's just scratching the surface!We started off by defining program design and experience design, and from there Sam talked about her label, Rosedale Collective, and her dedication to showcasing BIPOC voices in country music. She also dove into her previous work at The Obama Foundation, and how that opened her world to the importance of design in project management and social innovation (and for starting her own company, Viotty Design Studio). Sam even talked a bit about her current role at Adobe, and shared her plans on what she hopes to accomplish in the near future.Sam's career is a lesson in how we can all reshape our perspective on the conventional borders of design — something important to learn in this ever-changing world!LinksSam Viotty on InstgaramSam Viotty on LinkedInSam Viotty on Twitter / XFor a full transcript of this interview, visit revisionpath.com.==========Donate to Revision PathFor 10 years, Revision Path has been dedicated to showcasing Black designers and creatives from all over the world. In order to keep bringing you the content that you love, we need your support now more than ever.Click or tap here to make either a one-time or monthly donation to help keep Revision Path running strong.Thank you for your support!==========Follow and SubscribeLike this episode? Then subscribe to us on Apple Podcasts, Spotify, or wherever you find your favorite shows. Follow us, and leave us a 5-star rating and a review!You can also follow Revision Path on Instagram and Twitter.==========CreditsRevision Path is brought to you by Lunch, a multidisciplinary creative studio in Atlanta, GA.Executive Producer and Host: Maurice CherryEditor and Audio Engineer: RJ BasilioIntro Voiceover: Music Man DreIntro and Outro Music: Yellow SpeakerTranscripts are provided courtesy of Brevity and Wit.☎️ Call ‪626-603-0310 and leave us a message with your comments on this episode!Thank you for listening!==========Sponsored by Brevity & WitBrevity & Wit is a strategy and design firm committed to designing a more inclusive and equitable world. They are always looking to expand their roster of freelance design consultants in the U.S., particularly brand strategists, copywriters, graphic designers and Web developers.If you know how to deliver excellent creative work reliably, and enjoy the autonomy of a virtual-based, freelance life (with no non-competes), check them out at brevityandwit.com.Brevity & Wit — creative excellence without the grind.==========Sponsored by the School of Visual Arts - BFA Design & BFA AdvertisingThe BFA Design program at the School of Visual Arts consistently produces innovative and acclaimed work that is rooted in a strong foundational understanding of visual communication. It encourages creativity through cutting-edge tools, visionary design techniques, and offers burgeoning creatives a space to find their voice.Students in BFA Advertising are prepared for success in the dynamic advertising industry in a program led by faculty from New York's top ad agencies. Situated at the center of the advertising capital of the world, the program inspires the next generation of creative thinkers and elite professionals to design the future.School of Visual Arts has been a leader in the education of artists, designers and creative professionals for over seven decades. Comprising 7,000 students at its Manhattan campus and more than 41,000 alumni from 128 countries, SVA also represents one of the most influential artistic communities in the world. For information about the College's 30 undergraduate and graduate degree programs, visit sva.edu.

Business Group on Health
Cell and Gene Therapy: Tapping into the Potential of Curative Treatment

Business Group on Health

Play Episode Listen Later Nov 22, 2023 36:53


For patients diagnosed with rare diseases like hemophilia and muscular dystrophy, treatment has historically been difficult and the prognoses terminal....[…]

Connected Social Media
Cell and Gene Therapy: Tapping into the Potential of Curative Treatment

Connected Social Media

Play Episode Listen Later Nov 22, 2023 36:53


For patients diagnosed with rare diseases like hemophilia and muscular dystrophy, treatment has historically been difficult and the prognoses terminal....[…]

Ordinary Mind Zendo
The curative fantasies of mastery, service, and detachment

Ordinary Mind Zendo

Play Episode Listen Later Nov 1, 2023


The Pet Loss Companion
#135 A Story That Teaches the Differences Between Futile, Palliative, and Curative Care

The Pet Loss Companion

Play Episode Listen Later Oct 20, 2023 28:21


Join family therapists and authors Ken Dolan-Del Vecchio and Nancy Saxton-Lopez as we share stories from Nicole and Jenny, both of whom lost their beloved cats. Nicole's story gives us a poignant lesson that helps us understand the differences between futile, palliative, and curative care. Jenny's story illustrates how suddenly our lives can change through no fault of our own. Reach Ken at kenddv@gmail.com; Nancy at nsaxtonlopez@csmpc.com We are happy to announce our affiliation with Bereave, a company that offers beautifully crafted granite pet memorial plaques. When you purchase one of their plaques using the link that follows you are also supporting our podcast. https://shareasale.com/r.cfm?b=2399618&u=3798931&m=141340&urllink=&afftrack= To support our work on this podcast with a one-time gift: Venmo @Ken-Dolan-DelVecchio or ⁠⁠PayPal⁠⁠ (https://www.paypal.com/paypalme/kenddv?country.x=US&locale.x=en_US) To support this podcast with a monthly subscription: https://anchor.fm/kenneth-dolan-del-vecchio/support ⁠⁠The Pet Loss Companion (book) on Amazon⁠⁠: https://www.amazon.com/Pet-Loss-Companion-Healing-Therapists/dp/1484918266/ref=sr_1_3?dchild=1&keywords=pet+loss+companion&qid=1612535894&sr=8-3mpa... ⁠⁠To subscribe on YouTube⁠⁠: https://www.youtube.com/@thepetlosscompanion6602 (and hit the "subscribe" button) ⁠⁠To RSVP for the next cost-free zoom pet loss support group facilitated by Ken (November 14th at 6 pm ET)⁠⁠: https://www.dakinhumane.org/petloss.html This program is a friend of Dakin Humane Society in Springfield, Mass. Dakin is a 501 (c) (3) community-supported animal welfare organization that provides shelter, medical care, spay/neuter services, and behavioral rehabilitation for more than 20,000 animals and people each year. Since its inception in 1969, Dakin has become one of the most recognized nonprofit organizations in central Massachusetts and a national leader in animal welfare. You can learn more about Dakin and make a donation at ⁠⁠dakinhumane.org⁠⁠. For a list of financial resources to help with payment for veterinary care visit the ⁠⁠community tab on our YouTube channel⁠⁠: https://www.youtube.com/@thepetlosscompanion6602/community  and note the addition of  https://get.scratchpay.com/veterinary --- Send in a voice message: https://podcasters.spotify.com/pod/show/kenneth-dolan-del-vecchio/message Support this podcast: https://podcasters.spotify.com/pod/show/kenneth-dolan-del-vecchio/support

Austin Next
Balancing Stakeholder Interests in a Fast-Paced Innovative World with Dr. Isaac Turner, Co-founder and CTO of Curative

Austin Next

Play Episode Listen Later Sep 6, 2023 46:19


In this episode, we unpack the idea that innovation transcends the mere creation of new solutions. Through the lens of healthcare, and with insights from Dr. Isaac Turner, Co-founder and CTO of Curative, we delve into two key areas: how payment design can redefine user interactions, and the intricacies of diffusing groundbreaking innovations to ensure they're not only invented but also effectively adopted and utilized. While our discussions pivot around healthcare, the insights and challenges resonate across industries.Episode HighlightsCurative pivoted from COVID testing and vaccination programs to a vision to reshape the health insurance sector, emphasizing patient-centric care and efficiency.Central to Curative's approach is removing barriers to care. By eliminating copays, deductibles, and coinsurance for in-network services, and deploying non-clinical “care navigators” to assist members, they streamline the healthcare experience, encouraging patients to actively seek and manage their care.The distinct paradox for insurers lies is benefits like preventative care. Immediate financial returns are minimal and might even accrue to competitors due to customer turnover, while overall they are better for the patient and long term plan fiscal health. Obesity drugs such as Ozempic/Wegovy and advancements like cancer liquid biopsies highlight the intricacies of the diffusion of innovation in healthcare. Success hinges on aligning the interests of patients, providers, and payers, ensuring these solutions not only penetrate the market but also become accessible, adopted, and effectively utilize.Austin's dynamic growth, varied employment sectors, and a supportive healthcare regulatory backdrop made it Curative's prime choice as an innovation hub.What's next Austin? “We want to bring better benefits to more Austinites — expanding our footprint and getting the message out so that they can have zero-dollar coverage”Dr. Isaac Turner: LinkedIn, X/TwitterCurative: Website, LinkedIn, X/Twitter, YouTube, Facebook: Austin Next Links: Website, X/Twitter, YouTube, LinkedIn

The Uromigos
Episode 258: Curative radiotherapy for bladder cancer: Golden Ticket Winner #1

The Uromigos

Play Episode Listen Later Aug 15, 2023 46:19


Ananya Choudhury discussed the evidence for RT/TMT instead of surgery in muscle invasive bladder cancer. Regina Barragan-Carrillo (Golden Ticket Winner) introduces the podcast.

Psychedelics Today
PT422 – Oliver Carlin - Curative Mushrooms: Exploring the World of Grow Kits and Home Growing

Psychedelics Today

Play Episode Listen Later Jul 11, 2023 66:48


In this episode, Joe interviews Oliver Carlin, Founder of Curative Mushrooms, a grow kit solution company designed to produce mushrooms of one's choosing within 30 days with little effort and no growing experience.  Carlin tells his personal story of 20 years in the Navy to a 7g psilocybin journey and the work of perfecting these grow bags; how a grow bag works; how easy it can be to grow your own mushrooms; the advantages of growing your own mushrooms vs. buying them; the legalities of grow kits and how he has been able to do this; steps growers can take to reduce their legal risks; the variety of people benefitting from mushrooms (especially in the veteran community); and how growing your own mushrooms seems to make the experience more curated and special. Curative Mushrooms recently hired someone to create new strains for them every month, they do bimonthly live Q&As for people interested in growing, and they ship a bonus mycology book with each kit that shows how to study spores. They offer growing kits for Lion's Mane, Turkey Tail, and Shiitake mushrooms, but his most popular option is the “All-in-One Happy Mushrooms for Sad People” kit. Click here to go to the show notes page. 

Gut Check
Ep. 24 - Is Curative Metastatic Colon Cancer a Dream or Reality?

Gut Check

Play Episode Listen Later Jul 3, 2023 32:21


Is a more curative pathway for metastatic colon cancer patients emerging?  Join Biddy, Jon and Sam as they share cases, perspectives and approaches regarding metastatic colon cancer patients.   CO-HOSTS Biddy Das, MD, FACS Houston, TX (Twitter @BiddyDas) Dr. Bidhan “Biddy” Das has board certifications for both colon and rectal surgery, and general surgery. His passion for medical education and medical process improvement has resulted in book chapters and publications, and national and regional presentations on those subjects. Highlighting his medical expertise on fecal incontinence, he has been featured on patient education videos and national and international television and radio as a featured expert on these colorectal conditions. Dr Das also has a particular interest in surgeons redefining their careers -- he serves as both a software consultant and private equity consultant in Boston, New York City, and Houston.   Jonathan Abelson, MD, MS Arlington, MA (Twitter @jabelsonmd) Dr. Abelson was born and raised in Scarsdale, New York in the suburbs of New York City.  He has 2 older brothers and both of his parents are dentists.  Dr. Abelson went to college at University Pennsylvania, took 2 years off between college and medical school to work in healthcare consulting.  He then went to medical school at University of Virginia, returned to New York for general surgery residency at Weill Cornell on the upper east side of Manhattan.  Dr. Abelson then did colorectal fellowship at Washington University in St. Louis and am now at Lahey clinic in Burlington, Massachusetts for my first job after training.  He is 2 years into practice and has a wife and two sons. His wife works in wellness consulting and they have a dog named Foster who we adopted in St. Louis.   Sam Eisenstein, MD La Jolla, CA  (Twitter @DrE_UCSD) Sam Eisenstein is an Assistant Professor of Colon and rectal surgery and director of Inflammatory Bowel Disease surgery at UC San Diego Health.  He has worked there for the past 8 years after graduating both residency and fellowship at The Mount Sinai Medical Center in New York.  Sam is best known as the founder and organizer of the IBD-NSQIP collaborative, a large multi institutional data collaborative examining outcomes after IBD surgery, but he also is involved in several clinical trials for perianal Crohn's and has extensive experience with stem cell injections for anal fistulae. He is also on the scientific advisory board for the Crohn's and Colitis Foundation for his work on the next big IBD data collaborative, IBD-SIRQC (Surgical Innovation, Research and Quality Collaborative).  Sam has a Wife and 3 kids (6,8, and 3) and spends most of his free time running around after them these days, but also enjoys traveling and getting out into nature with his family.  

Texas Business Minds
Austin: Curative Founder & CEO Fred Turner's Quest to Disrupt Healthcare Delivery

Texas Business Minds

Play Episode Listen Later Jun 13, 2023 24:16


With a focus on preventative care, and described by its CEO as the "Netflix of healthcare", Curative is poised to disrupt the delivery model for care. In this download, Founder and CEO Fred Turner joins ABJ Managing Editor Will Anderson for an insightful conversation  that impacts business owners in Austin, and across the nation.

The Morning Fix by 510k Cafe
No Deductible? No Co-pay? No kidding! How Curative is reinventing Healthcare

The Morning Fix by 510k Cafe

Play Episode Listen Later May 10, 2023 23:14


Join co-hosts Amy Shepherd and Julie Dye of The Morning Fix by 510k Café podcast for a chat with Beth Henry, Chief Marketing Officer for Curative. In this episode, the co-hosts and guest discuss Curative's efforts in creating a new format and pathway to health insurance. For those interested in learning about ways companies are endeavoring to tackle the health insurance conundrum in US, this episode is for you. Notes from show: #healthinsurance #healthcare Learn more about your ad choices. Visit megaphone.fm/adchoices

This is Digital
Can Digital Cure Cancer?

This is Digital

Play Episode Listen Later Dec 20, 2022 19:14


As society becomes more tech-enabled, modern medicine is evolving–digital solutions are helping to change the definition of patient care and increase access to treatments. On this episode of This is Digital, Kevin Gordon, Chief Data Officer at Ori Biotech, joins us to share how digital is changing the field of cell and gene therapy–and how it can help solve some of healthcare's biggest challenges.Highlights:1:14 - Kevin's background in life sciences2:19 - Evolution of cell and gene therapy as inspiration2:50 - What is gene therapy?4:00 - Curative is different from treatment4:40 - When will we see the end of cancer?5:56 - The miraculous story of Emily Whitehead7:34 - Paper being the enemy of scale in life sciences8:35 - What level of digital is right for your business?10:25 - Real world examples11:40 - Opportunity for greater patient access?14:22 - Where will life sciences and Ori Biotech be in 3-5 years16:38 - What does digital mean to you?